Alembic Pharmaceuticals LimitedNSE: APLLTD

Press Release Aug 29 2022

Aug 29, 2022 at 3:26 PM UTC · Issued by Alembic Pharmaceuticals Limited

Alembic Pharmaceuticals Limited has informed the Exchange about press release dated 29-Aug-2022 titled Alembic Pharmaceuticals receives USFDA Final Approval for Chlorthalidone Tablets USP, 25 mg and 50 mg

View Attachment